Invention Grant
- Patent Title: Nucleic acid encoding and method of producing anti-IL-17A/IL-17F cross-reactive antibodies
-
Application No.: US13829733Application Date: 2013-03-14
-
Publication No.: US09650437B2Publication Date: 2017-05-16
- Inventor: Krzysztof Masternak , Olivier Leger
- Applicant: Novimmune S.A.
- Applicant Address: CH Geneva
- Assignee: NOVIMMUNE S.A.
- Current Assignee: NOVIMMUNE S.A.
- Current Assignee Address: CH Geneva
- Agency: Morrison & Foerster LLP
- Main IPC: C12P21/08
- IPC: C12P21/08 ; C07K16/24 ; A61K39/00
Abstract:
This invention provides fully human monoclonal antibodies that recognize IL-17F, the IL-17F homodimer, IL-17A, the IL-17A homodimer, and/or the heterodimeric IL-17A/IL-17F protein complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
Public/Granted literature
- US20130195872A1 ANTI-IL-17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2013-08-01
Information query
